Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ASTEC.NS Stock Summary
Top 10 Correlated ETFs
ASTEC.NS
In the News
ASTEC.NS Financial details
Company Rating
Neutral
Market Cap
25.28B
Income
-509.39M
Revenue
4.31B
Book val./share
-
Cash/share
-
Dividend
1.5
Dividend %
0.14%
Employees
551
Optionable
No
Shortable
Yes
Earnings
04 Apr 2024
P/E
-78.72
Forward P/E
-
PEG
5.03
P/S
4.08
P/B
5.13
P/C
-
P/FCF
6135.36
Quick Ratio
0.29
Current Ratio
0.93
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-25.98
EPS next Y
-
EPS next Q
-
EPS this Y
-71.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-6.53%
Revenue last 5Y
7.83%
Revenue Q/Q
-54.15%
EPS Q/Q
81.17%
-
-
-
-
SMA20
19.02%
SMA50
32%
SMA100
-0.55%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-13%
ROC
-0.02%
Gross Margin
33%
Oper. Margin
-2%
Profit Margin
-5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
825.05-1541.65
52W High
-19.38%
52W Low
+50.59%
RSI
65
Rel Volume
0.62
Avg Volume
73.51K
Volume
45.9K
Perf Week
-1.78%
Perf Month
37.68%
Perf Quarter
5.07%
Perf Half Y
-6.03%
-
-
-
-
Beta
0.34
-
-
Volatility
20.79%, 102.41%
Prev Close
-1.52%
Price
1242.35
Change
-0.69%
ASTEC.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 220.45 | 267.15 | 283.45 | 345.36 | 320.44 | |
Net income per share | 18.28 | 24.29 | 33.23 | 45.87 | 13.04 | |
Operating cash flow per share | 7.82 | 86.1 | -4.17 | 12.05 | 38.08 | |
Free cash flow per share | -19.18 | 62.95 | -56.54 | -41.03 | -21.73 | |
Cash per share | 0.23 | 1.19 | 0.79 | 1.71 | 1.4 | |
Book value per share | 103.59 | 126.04 | 157.94 | 202.4 | 213.93 | |
Tangible book value per share | 102.52 | 124.39 | 155.37 | 196.67 | 205.91 | |
Share holders equity per share | 103.59 | 126.04 | 157.94 | 202.4 | 213.93 | |
Interest debt per share | 96.2 | 56.9 | 98.05 | 147.23 | 184.61 | |
Market cap | 10.49B | 7.6B | 19.65B | 34.39B | 27.15B | |
Enterprise value | 12.24B | 8.58B | 21.52B | 37.17B | 30.56B | |
P/E ratio | 29.35 | 15.99 | 30.21 | 38.27 | 106.2 | |
Price to sales ratio | 2.43 | 1.45 | 3.54 | 5.08 | 4.32 | |
POCF ratio | 68.61 | 4.51 | -240.74 | 145.67 | 36.37 | |
PFCF ratio | -27.97 | 6.17 | -17.75 | -42.78 | -63.73 | |
P/B Ratio | 5.18 | 3.08 | 6.36 | 8.67 | 6.47 | |
PTB ratio | 5.18 | 3.08 | 6.36 | 8.67 | 6.47 | |
EV to sales | 2.84 | 1.64 | 3.88 | 5.49 | 4.86 | |
Enterprise value over EBITDA | 13.59 | 8.83 | 18.04 | 22.84 | 34.21 | |
EV to operating cash flow | 80.09 | 5.09 | -263.64 | 157.49 | 40.93 | |
EV to free cash flow | -32.65 | 6.97 | -19.44 | -46.25 | -71.73 | |
Earnings yield | 0.03 | 0.06 | 0.03 | 0.03 | 0.01 | |
Free cash flow yield | -0.04 | 0.16 | -0.06 | -0.02 | -0.02 | |
Debt to equity | 0.87 | 0.4 | 0.61 | 0.7 | 0.81 | |
Debt to assets | 0.38 | 0.17 | 0.28 | 0.31 | 0.35 | |
Net debt to EBITDA | 1.95 | 1.01 | 1.57 | 1.71 | 3.81 | |
Current ratio | 1 | 1.04 | 1.03 | 1.05 | 0.95 | |
Interest coverage | 5.54 | 5.44 | 18.88 | 13.29 | 2.1 | |
Income quality | 0.27 | 2.75 | -0.09 | 0.19 | 2.14 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.1 | 0.07 | 0.05 | 0.03 | 0.12 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Capex to operating cash flow | -3.45 | -0.27 | 12.56 | -4.41 | -1.57 | |
Capex to revenue | -0.12 | -0.09 | -0.18 | -0.15 | -0.19 | |
Capex to depreciation | -2.73 | -1.96 | -4 | -3.03 | -3.48 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 206.44 | 262.44 | 343.63 | 457.04 | 250.54 | |
ROIC | 0.12 | 0.15 | 0.13 | 0.13 | 0.04 | |
Return on tangible assets | 0.08 | 0.08 | 0.1 | 0.1 | 0.03 | |
Graham Net | -48.62 | -54.05 | -74.88 | -81.29 | -149.72 | |
Working capital | -3.27M | 133.88M | 81.54M | 250.89M | -273.47M | |
Tangible asset value | 2B | 2.43B | 3.04B | 3.85B | 4.04B | |
Net current asset value | -98.06M | 69.27M | -378.38M | 155.79M | -610.07M | |
Invested capital | 0.87 | 0.4 | 0.61 | 0.7 | 0.81 | |
Average receivables | 1.54B | 1.82B | 2.16B | 2.74B | 2.4B | |
Average payables | 815.92M | 1.33B | 1.64B | 1.57B | 1.84B | |
Average inventory | 856.64M | 1.07B | 1.14B | 1.47B | 2.41B | |
Days sales outstanding | 131.43 | 145.44 | 146.55 | 175.54 | 90.02 | |
Days payables outstanding | 81.94 | 216.84 | 131.97 | 177.28 | 161.18 | |
Days of inventory on hand | 120.28 | 129.82 | 112.17 | 174.59 | 268.21 | |
Receivables turnover | 2.78 | 2.51 | 2.49 | 2.08 | 4.05 | |
Payables turnover | 4.45 | 1.68 | 2.77 | 2.06 | 2.26 | |
Inventory turnover | 3.03 | 2.81 | 3.25 | 2.09 | 1.36 | |
ROE | 0.18 | 0.19 | 0.21 | 0.23 | 0.06 | |
Capex per share | -27 | -23.15 | -52.37 | -53.08 | -59.82 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 59.77 | 64.76 | 72.86 | 56.5 | 25.9 | |
Net income per share | 0.43 | -2.54 | -4.18 | -6.85 | -12.41 | |
Operating cash flow per share | 8.97 | 0.17 | 9.57 | 9.34 | 8.88 | |
Free cash flow per share | 8.97 | 0.17 | 9.57 | 9.34 | 8.88 | |
Cash per share | 38.22 | 1.4 | 0.24 | 2.25 | 0 | |
Book value per share | 216.14 | 213.9 | 213.99 | 201.44 | 0 | |
Tangible book value per share | 0 | 205.89 | 0 | 193.13 | 0 | |
Share holders equity per share | 216.14 | 213.9 | 213.99 | 201.44 | 0 | |
Interest debt per share | 3 | 177.28 | 3.3 | 223.05 | 3.11 | |
Market cap | 34.33B | 27.15B | 26.03B | 25.96B | 21.14B | |
Enterprise value | 35.08B | 30.56B | 26.04B | 30.26B | 21.14B | |
P/E ratio | 1.02K | -136.24 | -79.42 | -48.33 | -21.72 | |
Price to sales ratio | 29.3 | 21.39 | 18.22 | 23.43 | 41.62 | |
POCF ratio | 195.15 | 8.21K | 138.69 | 141.71 | 121.44 | |
PFCF ratio | 195.15 | 8.21K | 138.69 | 141.71 | 121.44 | |
P/B Ratio | 8.1 | 6.48 | 6.21 | 6.57 | 0 | |
PTB ratio | 8.1 | 6.48 | 6.21 | 6.57 | 0 | |
EV to sales | 29.94 | 24.07 | 18.23 | 27.32 | 41.62 | |
Enterprise value over EBITDA | 220.43 | 383.19 | 537.88 | -1.24K | -121.34 | |
EV to operating cash flow | 199.4 | 9.24K | 138.72 | 165.22 | 121.44 | |
EV to free cash flow | 199.4 | 9.24K | 138.72 | 165.22 | 121.44 | |
Earnings yield | 0 | 0 | 0 | -0.01 | -0.01 | |
Free cash flow yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0 | 0.81 | 0 | 1.09 | 0 | |
Debt to assets | 0 | 0.35 | 0 | 0.47 | 0 | |
Net debt to EBITDA | 4.71 | 42.72 | 0.1 | -176.22 | 0 | |
Current ratio | 0 | 0.95 | 0 | 0.93 | 0 | |
Interest coverage | 1.21 | 0.03 | -0.97 | -1.94 | -4.29 | |
Income quality | 20.95 | -0.07 | -2.29 | -1.36 | -0.72 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.02 | 0 | 0.02 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 45.64 | 110.6 | 141.86 | 176.17 | 0 | |
ROIC | 0.01 | 0 | -0.01 | -0.01 | 0 | |
Return on tangible assets | 0 | -0.01 | 0 | -0.02 | 0 | |
Graham Net | 38.22 | -149.7 | 0.24 | -166.51 | 0 | |
Working capital | 749.31M | -273.47M | 4.73M | -244.33M | 0 | |
Tangible asset value | 0 | 4.04B | 0 | 3.79B | 0 | |
Net current asset value | 749.31M | -610.07M | 4.73M | -1.66B | 0 | |
Invested capital | 0 | 0.81 | 0 | 1.09 | 0 | |
Average receivables | 1.12B | 774.6M | 774.6M | 509.22M | 509.22M | |
Average payables | 919M | 885.92M | 885.92M | 241.9M | 241.9M | |
Average inventory | 1.02B | 1.47B | 1.47B | 1.07B | 1.07B | |
Days sales outstanding | 0 | 109.81 | 0 | 82.73 | 0 | |
Days payables outstanding | 0 | 184.9 | 0 | 57.27 | 0 | |
Days of inventory on hand | 0 | 307.68 | 0 | 253.13 | 0 | |
Receivables turnover | 0 | 0.82 | 0 | 1.09 | 0 | |
Payables turnover | 0 | 0.49 | 0 | 1.57 | 0 | |
Inventory turnover | 0 | 0.29 | 0 | 0.36 | 0 | |
ROE | 0 | -0.01 | -0.02 | -0.03 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ASTEC.NS Frequently Asked Questions
What is Astec LifeSciences Limited stock symbol ?
Astec LifeSciences Limited is a IN stock and trading under the symbol ASTEC.NS
What is Astec LifeSciences Limited stock quote today ?
Astec LifeSciences Limited stock price is $1242.35 today.
Is Astec LifeSciences Limited stock public?
Yes, Astec LifeSciences Limited is a publicly traded company.